Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
Kearney K, Brown K, Celermajer DS, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Keating D, Keogh A, Kotlyar E, Lavender M, McWilliams T, Williams T, Whitford H, Weintraub R, Wrobel J, Ellender C, Anderson J, Lau EM; PHSANZ Registry. Kearney K, et al. Among authors: feenstra j. Chest. 2024 Apr;165(4):967-977. doi: 10.1016/j.chest.2023.10.037. Epub 2023 Nov 10. Chest. 2024. PMID: 37951349
Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Anderson JJ, Lau EM, Lavender M, Benza R, Celermajer DS, Collins N, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keating D, Kermeen F, Kotlyar E, McWilliams T, Rhodes B, Steele P, Thakkar V, Williams T, Whitford H, Whyte K, Weintraub R, Wrobel JP, Keogh A, Strange G. Anderson JJ, et al. Among authors: feenstra j. Chest. 2020 Jan;157(1):162-172. doi: 10.1016/j.chest.2019.08.2203. Epub 2019 Sep 26. Chest. 2020. PMID: 31563497
Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.
Khou V, Anderson JJ, Strange G, Corrigan C, Collins N, Celermajer DS, Dwyer N, Feenstra J, Horrigan M, Keating D, Kotlyar E, Lavender M, McWilliams TJ, Steele P, Weintraub R, Whitford H, Whyte K, Williams TJ, Wrobel JP, Keogh A, Lau EM. Khou V, et al. Among authors: feenstra j. Respirology. 2020 Aug;25(8):863-871. doi: 10.1111/resp.13768. Epub 2020 Jan 30. Respirology. 2020. PMID: 31997504
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges.
Anderson J, Lavender M, Lau E, Celermajer D, Collins N, Dwyer N, Feenstra J, Horrigan M, Keating D, Keogh A, Kotlyar E, Ng B, Proudman S, Steele P, Thakkar V, Weintraub R, Whitford H, Williams T, Wrobel J, Strange G. Anderson J, et al. Among authors: feenstra j. Heart Lung Circ. 2020 Oct;29(10):1459-1468. doi: 10.1016/j.hlc.2020.01.017. Epub 2020 Mar 6. Heart Lung Circ. 2020. PMID: 32280014
Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.
Ratwatte S, Anderson J, Strange G, Corrigan C, Collins N, Celermajer DS, Dwyer N, Feenstra J, Keating D, Kotlyar E, Lavender M, Whitford H, Whyte K, Williams T, Wrobel JP, Keogh A, Lau EM; PHSANZ Registry. Ratwatte S, et al. Among authors: feenstra j. Eur Respir J. 2020 Jul 9;56(1):1901654. doi: 10.1183/13993003.01654-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32341105 Free article.
Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
Chandrasekara S, Lau EM, Anderson J, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keogh A, Kotlyar E, Lavender M, McWilliams T, Rhodes B, Steele P, Strange G, Thakkar V, Weintraub R, Whitford H, Whyte K, Williams T, Wrobel J, Keating DT; PHSANZ Registry. Chandrasekara S, et al. Among authors: feenstra j. Heart Lung Circ. 2023 Feb;32(2):156-165. doi: 10.1016/j.hlc.2022.09.005. Epub 2022 Dec 8. Heart Lung Circ. 2023. PMID: 36503731
Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.
Strange G, Lau EM, Giannoulatou E, Corrigan C, Kotlyar E, Kermeen F, Williams T, Celermajer DS, Dwyer N, Whitford H, Wrobel JP, Feenstra J, Lavender M, Whyte K, Collins N, Steele P, Proudman S, Thakkar V, Keating D, Keogh A; PHSANZ Registry. Strange G, et al. Among authors: feenstra j. Heart Lung Circ. 2018 Nov;27(11):1368-1375. doi: 10.1016/j.hlc.2017.08.018. Epub 2017 Sep 20. Heart Lung Circ. 2018. PMID: 29029950
Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry.
Kearney K, Gold J, Corrigan C, Dhital K, Boshell D, Haydock D, McGiffin D, Wilson M, Collins N, Cordina R, Dwyer N, Feenstra J, Lavender M, Wrobel J, Whitford H, Williams T, Keating D, Whyte K, McWilliams T, Keogh A, Strange G, Kotlyar E, Anderson J, Lau EM. Kearney K, et al. Among authors: feenstra j. Respirology. 2021 Dec;26(12):1171-1180. doi: 10.1111/resp.14162. Epub 2021 Oct 5. Respirology. 2021. PMID: 34608706
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry.
Hoeper MM, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberà JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Ghofrani HA; Collaborators list. Hoeper MM, et al. Respir Med. 2021 Feb;177:106241. doi: 10.1016/j.rmed.2020.106241. Epub 2020 Dec 3. Respir Med. 2021. PMID: 33422952 Free article.
84 results